Tweet
February 14, 2025 • 12:30 pm CST
A recent study by the Finnish Institute for Health and Welfare (THL) shows that the Zoonotic Influenza Vaccine Seqirus injektioneste protects people against the disease caused by the currently circulating avian influenza viruses.
Since the summer of 2024, avian influenza vaccinations have been offered to occupational groups in the Republic of Finland at increased risk of the disease, such as those working with fur animals and poultry. They were offered Seqirus's vaccine, which the European Medicines Agency authorized.
Announced on February 13, 2025, the study showed that the vaccine-induced neutralizing antibodies identified the vaccine virus and the avian influenza viruses that caused the outbreaks on fur farms in Finland in 2023 and on dairy farms in the United States in 2024. ...
These 'bird flu' vaccines are not commercially available in the U.S.
A recent study by the Finnish Institute for Health and Welfare (THL) shows that the Zoonotic Influenza Vaccine Seqirus injektioneste protects people against the disease caused by the currently circulating avian influenza viruses.
Since the summer of 2024, avian influenza vaccinations have been offered to occupational groups in the Republic of Finland at increased risk of the disease, such as those working with fur animals and poultry. They were offered Seqirus's vaccine, which the European Medicines Agency authorized.
Announced on February 13, 2025, the study showed that the vaccine-induced neutralizing antibodies identified the vaccine virus and the avian influenza viruses that caused the outbreaks on fur farms in Finland in 2023 and on dairy farms in the United States in 2024. ...
These 'bird flu' vaccines are not commercially available in the U.S.